There are currently no reliable instruments for assessing the onset and progression of chronic obstructive pulmonary disease (COPD) or predicting its prognosis. Currently, a comprehensive assessment of COPD including several objective and subjective parameters is recommended. However, the lack of biomarkers precludes a correct assessment of COPD severity, which consequently hampers adequate therapeutic approaches and COPD control. In the absence of a definition of "well-controlled disease", a consensus regarding COPD control will be difficult to reach. However, COPD patient assessment should be multidimensional, and anchored in five points: control of symptoms, decline of pulmonary function, levels of physical activity, exacerbations, and Q...
AbstractThere is currently no consensus on the treatment sequence in chronic obstructive pulmonary d...
SummaryEvaluation of the effectiveness of treatment for chronic obstructive pulmonary disease (COPD)...
Chronic obstructive pulmonary disease (COPD) is the third leading cause of morbidity and mortality g...
AbstractThere are currently no reliable instruments for assessing the onset and progression of chron...
BACKGROUND: The concept of clinical control in COPD has been developed to help in treatment decision...
Patients with chronic obstructive pulmonary disease (COPD) present with a variety of symptoms that s...
Chronic obstructive pulmonary disease (COPD) is a leading cause of disability in all its stages, and...
There have been significant changes in the approach to the management of chronic obstructive pulmona...
Copyright © 2017. Published by Elsevier España, S.L.U.Chronic Obstructive Pulmonary Disease (COPD) e...
AbstractObjective: To systematically evaluate the quality of the development of guidelines for the m...
Copyright © 2003 Elsevier Science Ltd. All rights reserved.OBJECTIVE: To systematically evaluate the...
Background Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease whose assessment ...
Introduction: In 2011, the GOLD recommendations for the treatment of Chronic Obstructive Pulmonary D...
A gap exists between guidelines and real-world clinical practice for the management and treatment of...
COPD questionnaire good alternative for pulmonary function measurement Patients suffering from chro...
AbstractThere is currently no consensus on the treatment sequence in chronic obstructive pulmonary d...
SummaryEvaluation of the effectiveness of treatment for chronic obstructive pulmonary disease (COPD)...
Chronic obstructive pulmonary disease (COPD) is the third leading cause of morbidity and mortality g...
AbstractThere are currently no reliable instruments for assessing the onset and progression of chron...
BACKGROUND: The concept of clinical control in COPD has been developed to help in treatment decision...
Patients with chronic obstructive pulmonary disease (COPD) present with a variety of symptoms that s...
Chronic obstructive pulmonary disease (COPD) is a leading cause of disability in all its stages, and...
There have been significant changes in the approach to the management of chronic obstructive pulmona...
Copyright © 2017. Published by Elsevier España, S.L.U.Chronic Obstructive Pulmonary Disease (COPD) e...
AbstractObjective: To systematically evaluate the quality of the development of guidelines for the m...
Copyright © 2003 Elsevier Science Ltd. All rights reserved.OBJECTIVE: To systematically evaluate the...
Background Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease whose assessment ...
Introduction: In 2011, the GOLD recommendations for the treatment of Chronic Obstructive Pulmonary D...
A gap exists between guidelines and real-world clinical practice for the management and treatment of...
COPD questionnaire good alternative for pulmonary function measurement Patients suffering from chro...
AbstractThere is currently no consensus on the treatment sequence in chronic obstructive pulmonary d...
SummaryEvaluation of the effectiveness of treatment for chronic obstructive pulmonary disease (COPD)...
Chronic obstructive pulmonary disease (COPD) is the third leading cause of morbidity and mortality g...